期刊文献+

能力验证提供者认可准则在检验医学领域中的应用策略探讨 被引量:6

Study on the application strategy of the Accreditation Criteria for Proficiency Testing Providers in laboratory medicine
下载PDF
导出
摘要 检验医学的能力验证(PT)[或称室间质量评价(EQA)]是临床实验室质量保证的一个重要的方法。通过与其他实验室的结果比较分析,实验室可以发现和纠正工作中存在的问题,并采取有效措施预防问题的再次发生。随着医学科技的发展,为满足对疾病诊治的精准化需求,临床对实验室的检测能力提出了更高的要求。作为PT提供者,持续改进评价策略对实验室的质量提高将产生重要影响。近年来ISO/IEC17043:2010《能力验证提供者认可准则》在检验医学领域逐渐得到了重视和初步实践,文章对这次的PT专题刊登的6篇论著进行总结评价,希望通过PT提供者质量体系建设,为实验室提供质量评价保障的同时,推动实验室间结果的一致性和标准化。 Proficiency testing (PT) [ external quality assessment (EQA) ] in laboratory medicine is an important method for the quality assurance of clinical laboratories. By comparing the results with other laboratories, the laboratories can find out and correct the problems in their works, and take effective measures to prevent the recurrence of the problems. With the development of medical science and technology, in order to meet the needs of the clinical diagnosis and treatment of diseases, there are higher requirements for laboratory testing capacities. As PT providers, continuous improvement evaluation strategy will have an important impact on the quality of laboratory testing. In recent years, ISO/ 1EC17043:2010 the Accreditation Criteria for Proficiency Testing Providers in laboratory medicine has gradually been focused and practiced preliminarily. In this paper, we summarize the 6 papers published in this PT special topic. It is hoped that through establishing the quality system of PT providers, with the quality assurance for laboratory testing, the harmonization and standardization of laboratory results can also be promoted.
作者 居漪 吕元
出处 《检验医学》 CAS 2015年第11期1055-1058,1054,共4页 Laboratory Medicine
基金 上海市卫生和计划生育委员会资助项目(2013ZYJB0010) 上海市科学技术委员会科研计划项目(14441903503)
关键词 能力验证 正确度验证 认可准则 Proficiency testing Trueness-based proficiency testing Accreditation criterion
  • 相关文献

参考文献11

  • 1中国合格评定国家认可委员会.CNAS-CL03能力验证提供者认可准则(ISO/IEC 17043:2010)[S], 2010.
  • 2中国合格评定国家认可委员会.CNAS-GL03能力验证样品均匀性和稳定性评价指南[S].,2006..
  • 3中国合格评定国家认可委员会.CNAS-GL02能力验证结果的统计处理和能力评价指南[S]. 2014.
  • 4MILLER WG, JONES GR, HOROWITZ GL, et al.Proficiency testing/ external quality assessment:current challenges and future directions [ J ]. ClinChem,2011,57(12) : 1670-1680.
  • 5German Medical Association. Guidelines of theGerman Medical Association on quality assurance inmedical laboratory testing[ R]. Berin: GMA,2014.
  • 6College of American Pathologists. Accuracy-basedprograms. 2015 surveys and anatomic pathologyeducation programs[ R]. Northfleld: CAP,2015.
  • 7Clinical and Laboratory Standards Institute.Preparation and validation of commutable frozenhuman serum pools as secondary reference materialsfor cholesterol measurement procedures ; approvedguideline[S]. C37-A,CLSI, 1999.
  • 8Clinical and Laboratory Standards Institute. Userverification of performance for precision and trueness ;approved guideline [ S]. EP15-A2,CLSI,2006.
  • 9LITTLE RR, ROHLFING CL,SACKS DB. Status ofhemoglobin Ale measurement and goals forimprovement : from chaos to order for improvingdiabetes care[ J]. Clin Chem,2011,57(2) :205-214.
  • 10WEYKAMP C, JOHN G,GILLERY P, et al.Investigation of 2 models to set and evaluate qualitytargets for hb ale: biological variation and sigma-metrics. [J]. Clin Chem, 2015,61 (5) :752-759.

共引文献2

同被引文献41

  • 1周继凯,莫朝辉.促甲状腺激素测定的方法学进展及临床应用[J].中国医师杂志,2002,4(S1):115-116. 被引量:1
  • 2王志刚,曹浩强,殷新光.磁分离-酶标记-化学发光法测定促甲状腺素的应用[J].国外医学(临床生物化学与检验学分册),2005,26(4):193-195. 被引量:2
  • 3郑敏,罗建明.广西地区葡萄糖-6-磷酸脱氢酶缺乏症的流行病学调查和基因突变型鉴定[J].临床荟萃,2006,21(11):775-777. 被引量:17
  • 4李园园,李萍,宋昊岚,黄亨建,周君.应用6σ理论评价临床实验室各阶段性能及设计质控方案[J].中华检验医学杂志,2007,30(12):1408-1412. 被引量:15
  • 5Yan T, Cai R, Mo O, et al. Incidence and complete molec- ular characterization of glucose-6-phosphate dehydrogen- ase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations [J]. Haematologica,2006,91(10) : 1321-1328.
  • 6Elyassi AR,Rowshan HH. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature. Anesth Prog, 2009,56 (3) 86- 91.
  • 7Sameer YA, Amina SA, Fahima LA, et al. Lower refer- ence limits of quantitative cord glucose-6-phosphate dehy- drogenase estimated from healthy term neonates accord- ing to the clinical and laboratory standards institute guidelines . a cross sectional retrospective study[J]. BMC Pediatr,2013,13(1) :137.
  • 8Chiang SH, Wu KF, Liu TT, et al. Quality assurance pro- gram for neonatal screening of glucose-6-phosphate dehy- drogenase deficiency [ J ]. Southeast Asian J Trop Med Public Health,2003,34(3) :130-134.
  • 9Chiang SH, Fan ML, Hsiao KJ. External quality qssur- ance program for newborn screening of glucose-6-phos- phate dehydrogenase deficiency[J]. Ann Acad Med Sin- gapore,2008,37(3) :84-87.
  • 10von Seidlein L, Auburn S, Espino F, et al. Review of key knowledge gaps in glueose-6-phosphate dehydrogenase defi- ciency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens:a workshop report[J]. Malar J,2013,35(12) :112-133.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部